Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NSAIDs
NSAIDs
NSAIDs must display warning about pregnancy complications, FDA says
Beckers Hospital Review
Sun, 10/18/20 - 08:34 pm
FDA
NSAIDs
pregnancy
warnings
Anti-Inflammatory Drugs Could Make COVID-19 Symptoms Worse, Warns France's Health Minister
Motley Fool
Mon, 03/16/20 - 11:42 pm
NSAIDs
anti-inflammatories
COVID-19
Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
CP Wire
Wed, 08/29/18 - 10:38 am
Antibe Therapeutics
ATB-346
NSAIDs
naproxen
Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
Wed, 08/29/18 - 09:57 am
Antibe Therapeutics
ATB-346
NSAIDs
Study Suggests Some NSAIDs Associated With Increased Risk Of Heart Failure
Xtalks
Mon, 10/3/16 - 09:39 pm
NSAIDs
heart failure
FDA strengthens heart risk warning in popular pain relievers
Yahoo/AP
Thu, 07/9/15 - 07:48 pm
FDA
NSAIDs
warnings
New Study Shows That Common Pain Relievers Fight Bacterial Infections
Forbes
Mon, 03/17/14 - 11:26 am
superbugs
NSAIDs
antibiotics
MRSA
Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEX
Pipeline Review
Sat, 10/19/13 - 04:14 pm
Iroko Pharmaceuticals
Zorvolex
pain management
NSAIDs
Strong Phase III Ampion Data Released Wednesday: Setting The Stage For Ampio
Seeking Alpha
Thu, 08/15/13 - 10:22 am
Ampio Pharmaceuticals
NSAIDs
Ampion
High doses of common painkillers increase heart attack risks
Reuters
Thu, 05/30/13 - 08:58 am
ibuprofen
diclofenac
rheumatoid arthritis
NSAIDs
COX-2 inhibitors
FyMed Demonstrates Superiority of FY101C over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
CP Wire
Mon, 07/23/12 - 10:16 pm
FY101C
fymed
painkillers
NSAIDs
chronic pain
Painkillers linked to atrial fibrillation in Danish study
Pharma Times, UK
Tue, 07/5/11 - 11:52 am
painkillers
atrial fibrillation
NSAIDs
COX-2 inhibitors
Pozen Announces Achievement of $25 Million Milestone From AstraZeneca For VIMOVO(TM)
PipeLine Review
Sun, 11/14/10 - 01:04 pm
Pozen
Vimovo
AstraZeneca
NSAIDs
FDA takes up Javelin drug for review
Bizjournals.com
Wed, 02/3/10 - 06:46 am
FDA
Javelin
NSAIDs
Dyloject